Collate raises $95.0M Series B (United States, Jun 2026)

AI Startup Collate Raises $95 Million To Automate Life Sciences Paperwork - Forbes

Collate is an AI startup that develops tools to automate paperwork in the life sciences sector. The company targets pharmaceutical companies, medical device manufacturers, and biotech firms, aiming to streamline regulatory filings and clinical trials. With a recent funding round of $95 million, Collate is positioned to capitalize on the growing demand for AI solutions in life sciences documentation.

AI Startup Collate Raises $95 Million To Automate Life Sciences Paperwork  Forbes